BTAI - BioXcel Therapeutics GAAP EPS of -$0.87 misses by $0.12 revenue of $0.58M misses by $0.05M
2024-05-09 07:07:42 ET
More on BioXcel Therapeutics
- BioXcel Therapeutics, Inc. (BTAI) Q4 2023 Earnings Call Transcript
- BioXcel launches $25M direct offering of stock and warrants
- UBS cuts BioXcel to neutral; cites regulatory issues, financing
- Seeking Alpha’s Quant Rating on BioXcel Therapeutics
- Historical earnings data for BioXcel Therapeutics